Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-01 Sale | 2026-09-01 7:08 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $46.99 | $422,874 | 126,665 (Direct) | View |
| 2026-08-17 Sale | 2026-08-17 6:53 pm | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 7,576 | $49.23 | $372,937 | 102,193 (Direct) | View |
| 2026-08-03 Sale | 2026-08-03 7:16 pm | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 44,472 | $50.35 | $2,239,076 | 36,178 (Indirect Direct) | View |
| 2026-08-03 Sale | 2026-08-03 7:12 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $48.58 | $437,220 | 136,917 (Direct) | View |
| 2026-08-03 Sale | 2026-08-03 7:09 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $48.58 | $98,812 | 225,456 (Direct) | View |
| 2026-07-06 Sale | 2026-07-06 4:48 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $54.03 | $109,897 | 227,490 (Direct) | View |
| 2026-07-01 Sale | 2026-07-01 6:29 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $51.51 | $463,621 | 74,745 (Direct) | View |
| 2026-06-12 Sale | 2026-06-12 8:04 pm | Alkermes plc. | ALKS | Wright Christopher I Director | 2,000 | $45.1 | $90,200 | 25,680 (Direct) | View |
| 2026-06-04 Sale | 2026-06-04 5:00 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $43.05 | $87,564 | 229,524 (Direct) | View |
| 2026-06-01 Sale | 2026-06-01 7:26 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $41.67 | $375,044 | 83,745 (Direct) | View |
| 2026-05-29 Sale | 2026-05-29 6:03 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 16,217 | $42.36 | $687,007 | 23,937 (Direct) | View |
| 2026-05-04 Sale | 2026-05-04 8:42 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $33.2 | $67,529 | 231,558 (Direct) | View |
| 2026-05-01 Sale | 2026-05-01 9:05 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $33.4 | $300,560 | 92,745 (Direct) | View |
| 2026-04-06 Sale | 2026-04-06 7:56 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $34.57 | $70,315 | 233,592 (Direct) | View |
| 2026-04-01 Sale | 2026-04-01 6:58 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $35.51 | $319,604 | 101,745 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:19 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 6,890 | $29.29 | $201,808 | 36,926 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:18 pm | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,000 | $30 | $180,000 | 207,053 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:16 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $29.72 | $267,485 | 232,350 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:15 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 4,068 | $29.53 | $120,108 | 350,282 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-01 Exercise | 2026-09-01 7:08 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $24.59 | 126,665 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-01 7:08 pm | N/A 2032-02-18 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 126,665 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 9:17 pm | N/A 2036-08-05 | Alkermes plc. | ALKS | Jackson Blair Curtis President & CEO, Alkermes plc | 217,534 | $0 | 217,534 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 7:16 pm | N/A N/A | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 44,472 | $46.72 | 36,178 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 7:16 pm | N/A 2026-09-14 | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 44,472 | $0 | 36,178 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 7:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 104 | $19.34 | 136,917 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 7:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 4,896 | $24.59 | 136,917 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 7:12 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 136,917 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-01 6:29 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 74,745 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-01 6:29 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 74,745 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-01 7:26 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 83,745 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-01 7:26 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 83,745 (Direct) | View |
| 2026-05-29 Exercise | 2026-05-29 6:03 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 12,825 | $19.34 | 23,937 (Direct) | View |
| 2026-05-29 Exercise | 2026-05-29 6:03 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 3,392 | $20.03 | 23,937 (Direct) | View |
| 2026-05-29 Exercise | 2026-05-29 6:03 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 16,217 | $0 | 23,937 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:08 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | Wright Christopher I Director | 16,947 | $0 | 44,627 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:08 pm | N/A N/A | Alkermes plc. | ALKS | Wright Christopher I Director | 1,475 | $36.95 | 44,627 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:08 pm | N/A N/A | Alkermes plc. | ALKS | Wright Christopher I Director | 6,142 | $0 | 44,627 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:06 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | Wilson Frank Anders Director | 16,947 | $0 | 52,698 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:06 pm | N/A N/A | Alkermes plc. | ALKS | Wilson Frank Anders Director | 1,475 | $36.95 | 52,698 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:06 pm | N/A N/A | Alkermes plc. | ALKS | Wilson Frank Anders Director | 6,142 | $0 | 52,698 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:04 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 16,947 | $0 | 53,125 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:04 pm | N/A N/A | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 1,475 | $36.95 | 53,125 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:04 pm | N/A N/A | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 6,142 | $0 | 53,125 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:03 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | MCKEON BRIAN P Director | 16,947 | $0 | 65,483 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:03 pm | N/A N/A | Alkermes plc. | ALKS | MCKEON BRIAN P Director | 1,475 | $36.95 | 65,483 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:03 pm | N/A N/A | Alkermes plc. | ALKS | MCKEON BRIAN P Director | 6,142 | $0 | 65,483 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:01 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | Lurker Nancy Director | 16,947 | $0 | 35,169 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:01 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 1,475 | $36.95 | 35,169 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:01 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 6,142 | $0 | 35,169 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 8:00 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 16,947 | $0 | 50,716 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 8:00 pm | N/A N/A | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 1,475 | $36.95 | 50,716 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 8:00 pm | N/A N/A | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 6,142 | $0 | 50,716 (Direct) | View |
| 2026-05-20 Option Award(A) | 2026-05-22 7:59 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 16,947 | $0 | 16,947 (Direct) | View |
| 2026-05-20 Option Award(A) | 2026-05-22 7:58 pm | N/A 2036-05-20 | Alkermes plc. | ALKS | Cooke Shane Director | 16,947 | $0 | 16,947 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:59 pm | 2027-05-20 2036-05-20 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 16,947 | $0 | 52,698 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 4:59 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,475 | $36.95 | 52,698 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 4:59 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 6,142 | $0 | 52,698 (Direct) | View |
| 2026-05-20 Option Award | 2026-05-22 4:57 pm | 2027-05-20 2036-05-20 | Alkermes plc. | ALKS | Cooke Shane Director | 16,947 | $0 | 123,626 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-22 4:57 pm | N/A N/A | Alkermes plc. | ALKS | Cooke Shane Director | 3,207 | $36.95 | 123,626 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 4:57 pm | N/A N/A | Alkermes plc. | ALKS | Cooke Shane Director | 6,142 | $0 | 123,626 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-01 9:05 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 92,745 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-01 9:05 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 92,745 (Direct) | View |
| 2026-04-11 Exercise | 2026-04-13 5:09 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 3,751 | $0 | 17,307 (Direct) | View |
| 2026-04-11 Tax Withholding | 2026-04-13 5:09 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 901 | $33.36 | 17,307 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-01 6:58 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 101,745 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-01 6:58 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 101,745 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:21 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Reed Joshua SVP, Chief Financial Officer | 97,284 | $0 | 97,284 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:20 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 88,843 | $0 | 88,843 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:19 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 29,209 | $0 | 36,926 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:18 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 97,284 | $0 | 207,053 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:17 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 138,978 | $0 | 138,978 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:16 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 121,605 | $0 | 232,350 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-04 8:16 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 232,350 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-04 8:16 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 232,350 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:15 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 114,656 | $0 | 350,282 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,747 | $0 | 20,100 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 808 | $30.73 | 20,100 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 5,410 | $0 | 126,588 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 2,403 | $30.73 | 126,588 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,322 | $0 | 257,953 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,695 | $30.73 | 257,953 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:38 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 6,866 | $0 | 107,121 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:38 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,049 | $30.73 | 107,121 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:37 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 6,866 | $0 | 253,426 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:37 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 3,049 | $30.73 | 253,426 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:49 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,283 | $0 | 14,952 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:49 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 672 | $32.19 | 14,952 (Direct) | View |